Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2009 Mar 1;19(5):1508-11. doi: 10.1016/j.bmcl.2009.01.002. Epub 2009 Jan 9.

Aminofurazans as potent inhibitors of AKT kinase.

Author information

1
Oncology Chemistry, GlaxoSmithKline, Collegeville, PA 19426, USA.

Abstract

AKT inhibitors containing an imidazopyridine aminofurazan scaffold have been optimized. We have previously disclosed identification of the AKT inhibitor GSK690693, which has been evaluated in clinical trials in cancer patients. Herein we describe recent efforts focusing on investigating a distinct region of this scaffold that have afforded compounds (30 and 32) with comparable activity profiles to that of GSK690693.

PMID:
19179070
DOI:
10.1016/j.bmcl.2009.01.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center